| 2024-03-29 | MIFTSDTL | Single | AJCC TUMOR GRADE | | C135461 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | ALLRED PROPORTION POSITIVE SCORE | | C125985 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | ALLRED STAINING INTENSITY SCORE | | C125986 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | ALLRED TOTAL SCORE | | C125987 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | ALLRED TOTAL SCORE INTERPRETATION | | C199980 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | AVERAGE SHORTEST DISTANCES TO IM-WTR BOUNDARY | | C204668 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | BANFF QUANTITATIVE CRITERIA SCORE RENAL | | C135462 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | BATTS-LUDWIG FIBROSIS SCORE | | C119570 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | BAUERMEISTER SCORE | | C154808 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | BRESLOW DEPTH | | C25734 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | CAP TUMOR REGRESSION GRADE | | C181467 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | CHALKLEY SCORE | | C158254 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | COMBINED POSITIVE SCORE | | C204670 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | ENHANCED LIVER FIBROSIS SCORE | | C132429 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | EPSTEIN PROSTATE NEC CLASSIFICATION 2014 | | C199977 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | EUROPEAN CONSENSUS SCORE | | C154809 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | EVANS TUMOR REGRESSION GRADE 1992 | | C181469 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | FAB CLASSIFICATION 1985 | | C199981 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | FIGO TUMOR GRADE | | C187943 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | FUHRMAN NUCLEAR GRADE | | C62411 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | GHAS SCORE | | C178033 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | GLEASON PRIMARY SCORE | | C48603 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | GLEASON SECONDARY SCORE | | C48604 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | GLEASON TOTAL SUM | | C48602 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | H SCORE STAINING INTENSITY 0 | | C181473 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | H SCORE STAINING INTENSITY 1+ | | C181474 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | H SCORE STAINING INTENSITY 2+ | | C181475 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | H SCORE STAINING INTENSITY 3+ | | C181476 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | H SCORE TOTAL SCORE | | C125988 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | HARTMAN TUMOR REGRESSION GRADE 2012 | | C181470 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | IARC AND WHO CLASSIFICATION OF NEUROENDOCRINE NEOPLASMS 2018 | | C189619 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | IDWORAK TUMOR REGRESSION GRADE 1997 | | C181471 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | ISHAK FIBROSIS SCORE | | C95149 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | ISUP GLEASON GRADE GROUP | | C142346 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | JASS RECTAL CANCER PROGNOSTIC CLASSIFICATION 1987 | | C187944 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | KNODELL FIBROSIS SCORE | | C119571 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | MD ANDERSON TUMOR REGRESSION GRADE 2012 | | C181468 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | MEAN STAINING INTENSITY | | C204669 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | METAVIR FIBROSIS SCORE | | C119572 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | METMAB SCORE | | C174344 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | NAFLD ACTIVITY SCORE | | C181472 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | NOTTINGHAM HISTOLOGIC GRADE | | C138986 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | NUMBER | | C25463 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | PERCENT POSITIVE CELL | | C70460 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | POSITIVE CELL COUNT | | C156548 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | POSITIVE CELLS AREA | | C204667 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | PROLIFERATIVE INDEX | | C28042 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | RECEPTOR OVERALL STATUS | | C125989 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | RHI SCORE | | C178034 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | SCHEUER FIBROSIS SCORE | | C119573 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | STAINING INTENSITY | | C127762 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | STAINING INTENSITY 0 | | C186199 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | STAINING INTENSITY 1+ | | C186200 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | STAINING INTENSITY 2+ | | C186201 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | STAINING INTENSITY 3+ | | C186202 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | STAINING PATTERN | | C189492 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | TUMOR PROPORTION SCORE | | C154810 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | UNSPECIFIED TUMOR GRADE CLASSIFICATION | | C199978 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | WHO CLASSIFICATION OF TUMORS OF ENDOCRINE ORGANS 2017 | | C189617 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | WHO CLASSIFICATION OF TUMORS OF HEMATOPOIETIC AND LYMPHOID TISSUE 2017 | | C199979 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | WHO CLASSIFICATION OF TUMORS OF THE DIGESTIVE SYSTEM 2010 | | C189616 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | WHO CLASSIFICATION OF TUMORS OF THE DIGESTIVE SYSTEM 2019 | | C189618 | C125922 | | |
| 2024-03-29 | MIFTSDTL | Single | WHO/ISUP NUCLEAR GRADE | | C187945 | C125922 | | |